Following on the theme of "perceptions" from yesterday’s post, today I would like to cover more on regulation, risk management, safety and ethics. These are topics that I will cover on a regular basis.
The following are excerpts from the first week of February, 2007.
"Nanotechnology—the so-called "science of the small"—is raising some really big questions about the adequacy of the current federal oversight system. The Environmental Protection Agency (EPA) is grappling with understanding the jurisdiction and applicability of major laws, like the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), with respect to nanotechnology. The Food and Drug Administration (FDA) is evaluating the effectiveness of the agency's regulatory approaches and authorities to meet the potential unique challenges presented by the use of nanomaterials in FDA-regulated products, and the agency expects to issue its findings in July 2007."
(From: Nanotechnology: Thinking Big About Things Small http://www.nanotech-now.com/news.cgi?story_id=21015)
"A Swiss firm is offering the first process risk management and safety certification for pharma companies working with nanoparticles and technologies. A Swiss firm is offering the first process risk management and safety certification for pharma companies working with nanoparticles and technologies."
(From: World's first nanospecific safety label http://www.in-pharmatechnologist.com/news/ng.asp?n=74792-the-innovation-society-cenarios-nanotechnology-safety-drug-delivery)
"Despite the potential benefits to agrifood producers, retailers and consumers, nanotechnology’s applications in the food industry are a reason for concern for many. Stone points out that privacy and control issues associated with agrifood and nanotechnology are likely to be among several hot-button issues."
(From: Old food meets new technologies, leaves food for thought
http://msutoday.msu.edu/research/index.php3?article=02Mar2007-5)
"A greater understanding of the interaction of nanomaterials with biological systems, especially of the interaction of nanomaterials with cell membranes, will enable scientists to take full advantage of the unique properties of nanomaterials while minimizing their adverse effects."
(From: The challenge of designing nanomaterials with reduced toxicity http://www.nanotech-now.com/news.cgi?story_id=20890)
"The NEW Precise(TM) HEPA-Filtered Glove Boxes provide a physical barrier to protect the operator form hazardous airborne particulates and powders. These economical boxes have uses in pharmaceutical research, nanotechnology and biochemistry applications."
(From: Glove Boxes protect user from hazardous particulates http://news.thomasnet.com/fullstory/509859/1424)
"There are two kinds of ethicists. The first kind makes you think about what it is you want, and why. The second kind tells you what you should want. The first kind of ethicist is very valuable. The second can be damaging."
(From: Exploring Nano-Ethics http://ieet.org/index.php/IEET/more/phoenix20070227/)
For custom reports in your areas of interest, contact me at rocky at bir-consulting.com
The following are excerpts from the first week of February, 2007.
"Nanotechnology—the so-called "science of the small"—is raising some really big questions about the adequacy of the current federal oversight system. The Environmental Protection Agency (EPA) is grappling with understanding the jurisdiction and applicability of major laws, like the Toxic Substances Control Act (TSCA) and the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), with respect to nanotechnology. The Food and Drug Administration (FDA) is evaluating the effectiveness of the agency's regulatory approaches and authorities to meet the potential unique challenges presented by the use of nanomaterials in FDA-regulated products, and the agency expects to issue its findings in July 2007."
(From: Nanotechnology: Thinking Big About Things Small http://www.nanotech-now.com/news.cgi?story_id=21015)
"A Swiss firm is offering the first process risk management and safety certification for pharma companies working with nanoparticles and technologies. A Swiss firm is offering the first process risk management and safety certification for pharma companies working with nanoparticles and technologies."
(From: World's first nanospecific safety label http://www.in-pharmatechnologist.com/news/ng.asp?n=74792-the-innovation-society-cenarios-nanotechnology-safety-drug-delivery)
"Despite the potential benefits to agrifood producers, retailers and consumers, nanotechnology’s applications in the food industry are a reason for concern for many. Stone points out that privacy and control issues associated with agrifood and nanotechnology are likely to be among several hot-button issues."
(From: Old food meets new technologies, leaves food for thought
http://msutoday.msu.edu/research/index.php3?article=02Mar2007-5)
"A greater understanding of the interaction of nanomaterials with biological systems, especially of the interaction of nanomaterials with cell membranes, will enable scientists to take full advantage of the unique properties of nanomaterials while minimizing their adverse effects."
(From: The challenge of designing nanomaterials with reduced toxicity http://www.nanotech-now.com/news.cgi?story_id=20890)
"The NEW Precise(TM) HEPA-Filtered Glove Boxes provide a physical barrier to protect the operator form hazardous airborne particulates and powders. These economical boxes have uses in pharmaceutical research, nanotechnology and biochemistry applications."
(From: Glove Boxes protect user from hazardous particulates http://news.thomasnet.com/fullstory/509859/1424)
"There are two kinds of ethicists. The first kind makes you think about what it is you want, and why. The second kind tells you what you should want. The first kind of ethicist is very valuable. The second can be damaging."
(From: Exploring Nano-Ethics http://ieet.org/index.php/IEET/more/phoenix20070227/)
For custom reports in your areas of interest, contact me at rocky at bir-consulting.com
No comments:
Post a Comment